572 studies found for:    Open Studies | "Ovarian Diseases"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Ovarian Diseases"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Cancer Screening Program for Women at High Risk for Developing Ovarian Cancer
Conditions: Ovarian Diseases;   Ovarian Neoplasms
Interventions: Other: Laboratory Tumor Marker Analysis;   Other: Transvaginal Ultrasound;   Other: Health Status Questionnaire
2 Recruiting Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Fallopian Tube Cancer
Intervention: Drug: BIBF 1120
3 Recruiting Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone
Conditions: Polycystic Ovary Syndrome;   Hyperandrogenism
Interventions: Drug: Progesterone;   Drug: Placebo
4 Recruiting MLN0128 and Ziv-Aflibercept in Treating Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Gastrinoma;   Glucagonoma;   Insulinoma;   Pancreatic Polypeptide Tumor;   Recurrent Islet Cell Carcinoma;   Recurrent Ovarian Epithelial Cancer;   Recurrent Ovarian Germ Cell Tumor;   Somatostatinoma;   Stage IIIA Ovarian Epithelial Cancer;   Stage IIIA Ovarian Germ Cell Tumor;   Stage IIIB Ovarian Epithelial Cancer;   Stage IIIB Ovarian Germ Cell Tumor;   Stage IIIC Ovarian Epithelial Cancer;   Stage IIIC Ovarian Germ Cell Tumor;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: TORC1/2 inhibitor MLN0128;   Biological: ziv-aflibercept;   Other: laboratory biomarker analysis
5 Recruiting Studying DNA in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer
Condition: Ovarian Cancer
Interventions: Genetic: DNA methylation analysis;   Genetic: microarray analysis;   Genetic: polymerase chain reaction;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis
6 Recruiting INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Drug: Carboplatin;   Drug: Pegylated Lipoxomal Doxorubicin (PLD);   Drug: Trabectedin
7 Recruiting Stress Reduction in Ovarian Cancer
Condition: Ovarian, Fallopian, and Primary Peritoneal Cancer
Interventions: Behavioral: Daily stress reduction program;   Other: Attention control
8 Recruiting Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors
Conditions: Breast Cancer;   Ovarian Cancer;   Gynecological Cancer;   Head and Neck Carcinoma;   Non-small Cell Lung Cancer;   Small Cell Lung Cancer;   Non-squamous Cell Lung Cancer
Intervention: Drug: PM01183 + paclitaxel +/- bevacizumab
9 Recruiting EURAD-MR Classification : European Multicenter Study
Condition: Ovarian Tumor
Intervention:
10 Recruiting Prophylactic Salpingectomy With Delayed Oophorectomy
Condition: Ovarian Carcinoma
Interventions: Other: Ovarian Cancer Screening;   Procedure: Prophylactic Salpingectomy with Delayed Oophorectomy;   Procedure: Risk-Reducing Salpingo-Oophorectomy;   Behavioral: Questionnaire;   Procedure: Transvaginal Ultrasound;   Behavioral: Phone Call
11 Recruiting Stem Cell Therapy Combined Hormone Replacement Therapy in Patients With Premature Ovarian Failure
Condition: Premature Ovarian Failure,
Interventions: Biological: human umbilical cord mesenchymal stem cells;   Biological: hUCMSCs and hCBMNCs;   Biological: human cord blood mononuclear cells;   Drug: Hormone Replacement Therapy
12 Recruiting Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Conditions: Fallopian Tube Cancer;   Ovarian Cancer;   Peritoneal Cancer;   Uterine Cancer;   Vaginal Cancer;   Vulvar Cancer
Intervention: Behavioral: online platform WEBCORE
13 Unknown  Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction
Conditions: Hyperandrogenemia;   Obesity;   Polycystic Ovary Syndrome
Interventions: Drug: Hydrocortisone;   Drug: dexamethasone;   Drug: Cosyntropin;   Drug: r-hCG (Ovidrel)
14 Recruiting Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Conditions: Breast Cancer;   Ovarian Cancer;   Gynecologic Cancers;   Ovarian/Peritoneal/Fallopian Cancer
Intervention:
15 Recruiting Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel
Conditions: Breast Cancer;   Ovarian Neoplasm;   Pain
Interventions: Dietary Supplement: omega-3 fatty acid;   Dietary Supplement: placebo;   Other: quality-of-life assessment
16 Unknown  'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"
Conditions: Male Infertility;   Female Infertility;   Ovarian Hyperstimulation Syndrome;   Premature Ovarian Failure;   Endometriosis
Interventions: Behavioral: patient education;   Behavioral: professional audit and feedback (guideline adherence);   Behavioral: professional education (communication/shared decision making);   Other: information tools
17 Not yet recruiting An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer
Condition: Ovarian Cancer, Peritoneal Neoplasms
Intervention:
18 Unknown  Blood Test for Ovarian Cancer Associated Antibodies (CAAb)
Condition: Ovarian Cancer
Intervention: Procedure: Find Cancer Associated Antibodies
19 Recruiting Tumor Bank for Blood Samples
Conditions: Ovarian Neoplasms;   Breast Neoplasms;   Colorectal Neoplasms;   Neoplasms of the Female Genitalia;   Lung Neoplasms;   Endocrine Gland Neoplasms
Intervention: Other: Blood collection
20 Not yet recruiting H.O.P.E: Helping Ovarian Cancer Patients Cope
Conditions: Platinum-resistant Ovarian Cancer;   Recurrent Ovarian Cancer;   Palliative Care
Interventions: Other: Structured Palliative Care;   Other: Usual Care

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years